Back to ALL Research Publications
![]()
Research Category: Detection of Bacterial Burden, Chronic Wounds
New horizons in the understanding of the causes and management of diabetic foot disease: report from the 2017 Diabetes UK Annual Professional Conference Symposium
References
1Department of Infection, Immunity and Inflammation, University of Leicester, Leicester.
2Medical School, Cardiff University, Heath Park, Cardiff.
3Welsh Wound Innovation Centre, Rhodfa Marics, Ynysmaerdy, Rhondda Cynon Taf.
4Department of Health Psychology, Division of Primary Care, Nottingham University,
Nottingham.
5Department of Diabetes, Derby Teaching Hospitals NHS Foundation Trust, Derby.
6Elsie Bertram Diabetes Centre, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK.
Ready to see the difference?
MolecuLight is SOC ll®
Type l Accredited:
MolecuLight awarded
Premier’s Technology
Breakthrough Designation
MolecuLight i:X
is designated as a:
MolecuLight included
in ISWCAP Consensus
Guidelines:
MolecuLight is a proud
corporate member of:
Global
USA
©2024
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.
References
1Department of Infection, Immunity and Inflammation, University of Leicester, Leicester.
2Medical School, Cardiff University, Heath Park, Cardiff.
3Welsh Wound Innovation Centre, Rhodfa Marics, Ynysmaerdy, Rhondda Cynon Taf.
4Department of Health Psychology, Division of Primary Care, Nottingham University,
Nottingham.
5Department of Diabetes, Derby Teaching Hospitals NHS Foundation Trust, Derby.
6Elsie Bertram Diabetes Centre, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK.